Enzastaurin to Treat Recurrent Brain Tumor
NCT00108056
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
26
Enrollment
NIH
Sponsor class
Conditions
Glioma
Interventions
DRUG:
Enzastaurin (LY317615) monohydronchloride
Sponsor
National Cancer Institute (NCI)